Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo

Megan M. Multhaup, Sweta Gurram, Kelly M. Podetz-Pedersen, Andrea D. Karlen, Debra L. Swanson, Nikunj V Somia, Perry B Hackett, Morton J. Cowan, R S Mc Ivor

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Artemis is an endonucleolytic enzyme involved in nonhomologous double-strand break repair and V(D)J recombination. Deficiency of Artemis results in a B - T - radiosensitive severe combined immunodeficiency, which may potentially be treatable by Artemis gene transfer into hematopoietic stem cells. However, we recently found that overexpression of Artemis after lentiviral transduction resulted in global DNA damage and increased apoptosis. These results imply the necessity of effecting natural levels of Artemis expression, so we isolated a 1 kilobase DNA sequence upstream of the human Artemis gene to recover and characterize the Artemis promoter (APro). The sequence includes numerous potential transcription factor-binding sites, and several transcriptional start sites were mapped by 5′ rapid amplification of cDNA ends. APro and deletion constructs conferred significant reporter gene expression in vitro that was markedly reduced in comparison to expression regulated by the human elongation factor 1-α promoter. Ex vivo lentiviral transduction of an APro-regulated green fluorescent protein (GFP) construct in mouse marrow supported GFP expression throughout hematopoeitic lineages in primary transplant recipients and was sustained in secondary recipients. The human Artemis promoter thus provides sustained and moderate levels of gene expression that will be of significant utility for therapeutic gene transfer into hematopoeitic stem cells.

Original languageEnglish (US)
Pages (from-to)751-761
Number of pages11
JournalDNA and Cell Biology
Volume30
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Green Fluorescent Proteins
Gene Expression
V(D)J Recombination
Genes
Peptide Elongation Factor 1
Severe Combined Immunodeficiency
Hematopoietic Stem Cells
Reporter Genes
DNA Damage
Transcription Factors
Stem Cells
Complementary DNA
Bone Marrow
Binding Sites
Apoptosis
Enzymes
In Vitro Techniques
Therapeutics
Transplant Recipients

Cite this

Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo. / Multhaup, Megan M.; Gurram, Sweta; Podetz-Pedersen, Kelly M.; Karlen, Andrea D.; Swanson, Debra L.; Somia, Nikunj V; Hackett, Perry B; Cowan, Morton J.; Mc Ivor, R S.

In: DNA and Cell Biology, Vol. 30, No. 10, 01.10.2011, p. 751-761.

Research output: Contribution to journalArticle

Multhaup, Megan M. ; Gurram, Sweta ; Podetz-Pedersen, Kelly M. ; Karlen, Andrea D. ; Swanson, Debra L. ; Somia, Nikunj V ; Hackett, Perry B ; Cowan, Morton J. ; Mc Ivor, R S. / Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo. In: DNA and Cell Biology. 2011 ; Vol. 30, No. 10. pp. 751-761.
@article{745ce863349f4ab38904c0d27dd3ac59,
title = "Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo",
abstract = "Artemis is an endonucleolytic enzyme involved in nonhomologous double-strand break repair and V(D)J recombination. Deficiency of Artemis results in a B - T - radiosensitive severe combined immunodeficiency, which may potentially be treatable by Artemis gene transfer into hematopoietic stem cells. However, we recently found that overexpression of Artemis after lentiviral transduction resulted in global DNA damage and increased apoptosis. These results imply the necessity of effecting natural levels of Artemis expression, so we isolated a 1 kilobase DNA sequence upstream of the human Artemis gene to recover and characterize the Artemis promoter (APro). The sequence includes numerous potential transcription factor-binding sites, and several transcriptional start sites were mapped by 5′ rapid amplification of cDNA ends. APro and deletion constructs conferred significant reporter gene expression in vitro that was markedly reduced in comparison to expression regulated by the human elongation factor 1-α promoter. Ex vivo lentiviral transduction of an APro-regulated green fluorescent protein (GFP) construct in mouse marrow supported GFP expression throughout hematopoeitic lineages in primary transplant recipients and was sustained in secondary recipients. The human Artemis promoter thus provides sustained and moderate levels of gene expression that will be of significant utility for therapeutic gene transfer into hematopoeitic stem cells.",
author = "Multhaup, {Megan M.} and Sweta Gurram and Podetz-Pedersen, {Kelly M.} and Karlen, {Andrea D.} and Swanson, {Debra L.} and Somia, {Nikunj V} and Hackett, {Perry B} and Cowan, {Morton J.} and {Mc Ivor}, {R S}",
year = "2011",
month = "10",
day = "1",
doi = "10.1089/dna.2011.1244",
language = "English (US)",
volume = "30",
pages = "751--761",
journal = "DNA and Cell Biology",
issn = "1044-5498",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo

AU - Multhaup, Megan M.

AU - Gurram, Sweta

AU - Podetz-Pedersen, Kelly M.

AU - Karlen, Andrea D.

AU - Swanson, Debra L.

AU - Somia, Nikunj V

AU - Hackett, Perry B

AU - Cowan, Morton J.

AU - Mc Ivor, R S

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Artemis is an endonucleolytic enzyme involved in nonhomologous double-strand break repair and V(D)J recombination. Deficiency of Artemis results in a B - T - radiosensitive severe combined immunodeficiency, which may potentially be treatable by Artemis gene transfer into hematopoietic stem cells. However, we recently found that overexpression of Artemis after lentiviral transduction resulted in global DNA damage and increased apoptosis. These results imply the necessity of effecting natural levels of Artemis expression, so we isolated a 1 kilobase DNA sequence upstream of the human Artemis gene to recover and characterize the Artemis promoter (APro). The sequence includes numerous potential transcription factor-binding sites, and several transcriptional start sites were mapped by 5′ rapid amplification of cDNA ends. APro and deletion constructs conferred significant reporter gene expression in vitro that was markedly reduced in comparison to expression regulated by the human elongation factor 1-α promoter. Ex vivo lentiviral transduction of an APro-regulated green fluorescent protein (GFP) construct in mouse marrow supported GFP expression throughout hematopoeitic lineages in primary transplant recipients and was sustained in secondary recipients. The human Artemis promoter thus provides sustained and moderate levels of gene expression that will be of significant utility for therapeutic gene transfer into hematopoeitic stem cells.

AB - Artemis is an endonucleolytic enzyme involved in nonhomologous double-strand break repair and V(D)J recombination. Deficiency of Artemis results in a B - T - radiosensitive severe combined immunodeficiency, which may potentially be treatable by Artemis gene transfer into hematopoietic stem cells. However, we recently found that overexpression of Artemis after lentiviral transduction resulted in global DNA damage and increased apoptosis. These results imply the necessity of effecting natural levels of Artemis expression, so we isolated a 1 kilobase DNA sequence upstream of the human Artemis gene to recover and characterize the Artemis promoter (APro). The sequence includes numerous potential transcription factor-binding sites, and several transcriptional start sites were mapped by 5′ rapid amplification of cDNA ends. APro and deletion constructs conferred significant reporter gene expression in vitro that was markedly reduced in comparison to expression regulated by the human elongation factor 1-α promoter. Ex vivo lentiviral transduction of an APro-regulated green fluorescent protein (GFP) construct in mouse marrow supported GFP expression throughout hematopoeitic lineages in primary transplant recipients and was sustained in secondary recipients. The human Artemis promoter thus provides sustained and moderate levels of gene expression that will be of significant utility for therapeutic gene transfer into hematopoeitic stem cells.

UR - http://www.scopus.com/inward/record.url?scp=80053523133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053523133&partnerID=8YFLogxK

U2 - 10.1089/dna.2011.1244

DO - 10.1089/dna.2011.1244

M3 - Article

VL - 30

SP - 751

EP - 761

JO - DNA and Cell Biology

JF - DNA and Cell Biology

SN - 1044-5498

IS - 10

ER -